Tuberculosis (TB) Diagnostics Industry Research Report 2024
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to APO Research, The global Tuberculosis (TB) Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Tuberculosis (TB) Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
- Diagnostic Laboratories
- Hospitals
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Tuberculosis (TB) Diagnostics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Culture-Based Diagnostics
2.2.3 Sputum Smear Microscopy
2.2.4 Rapid Molecular Diagnostics
2.2.5 Others
2.3 Tuberculosis (TB) Diagnostics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diagnostic Laboratories
2.3.3 Hospitals
2.4 Assumptions and Limitations
3 TUBERCULOSIS (TB) DIAGNOSTICS BREAKDOWN DATA BY TYPE
3.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2025-2030)
4 TUBERCULOSIS (TB) DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2019-2024)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2019-2030)
5.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
5.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2019-2024)
5.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2025-2030)
5.3 Tuberculosis (TB) Diagnostics Market Dynamics
5.3.1 Tuberculosis (TB) Diagnostics Industry Trends
5.3.2 Tuberculosis (TB) Diagnostics Market Drivers
5.3.3 Tuberculosis (TB) Diagnostics Market Challenges
5.3.4 Tuberculosis (TB) Diagnostics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
6.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2019-2024)
6.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2019-2024)
6.2 Global Tuberculosis (TB) Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served
6.4 Global Tuberculosis (TB) Diagnostics Players, Product Type & Application
6.5 Global Tuberculosis (TB) Diagnostics Players, Date of Enter into This Industry
6.6 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
7.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Tuberculosis (TB) Diagnostics Market Size (2019-2030)
8.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
8.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2019-2030)
9.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
9.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
10.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2019-2030)
11.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
11.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Danaher
12.1.1 Danaher Company Information
12.1.2 Danaher Business Overview
12.1.3 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
12.1.5 Danaher Recent Developments
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Business Overview
12.2.3 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
12.2.5 Roche Recent Developments
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Information
12.3.2 Thermo Fisher Scientific Business Overview
12.3.3 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
12.3.5 Thermo Fisher Scientific Recent Developments
12.4 BD
12.4.1 BD Company Information
12.4.2 BD Business Overview
12.4.3 BD Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
12.4.5 BD Recent Developments
12.5 Abbott
12.5.1 Abbott Company Information
12.5.2 Abbott Business Overview
12.5.3 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
12.5.5 Abbott Recent Developments
12.6 Hologic
12.6.1 Hologic Company Information
12.6.2 Hologic Business Overview
12.6.3 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
12.6.5 Hologic Recent Developments
12.7 Qiagen
12.7.1 Qiagen Company Information
12.7.2 Qiagen Business Overview
12.7.3 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
12.7.5 Qiagen Recent Developments
12.8 BioMerieux
12.8.1 BioMerieux Company Information
12.8.2 BioMerieux Business Overview
12.8.3 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
12.8.5 BioMerieux Recent Developments
12.9 Hain Lifescience
12.9.1 Hain Lifescience Company Information
12.9.2 Hain Lifescience Business Overview
12.9.3 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
12.9.5 Hain Lifescience Recent Developments
12.10 Oxford Immunotec
12.10.1 Oxford Immunotec Company Information
12.10.2 Oxford Immunotec Business Overview
12.10.3 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
12.10.5 Oxford Immunotec Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Tuberculosis (TB) Diagnostics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Culture-Based Diagnostics
2.2.3 Sputum Smear Microscopy
2.2.4 Rapid Molecular Diagnostics
2.2.5 Others
2.3 Tuberculosis (TB) Diagnostics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diagnostic Laboratories
2.3.3 Hospitals
2.4 Assumptions and Limitations
3 TUBERCULOSIS (TB) DIAGNOSTICS BREAKDOWN DATA BY TYPE
3.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2025-2030)
4 TUBERCULOSIS (TB) DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2019-2024)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2019-2030)
5.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
5.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2019-2024)
5.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2025-2030)
5.3 Tuberculosis (TB) Diagnostics Market Dynamics
5.3.1 Tuberculosis (TB) Diagnostics Industry Trends
5.3.2 Tuberculosis (TB) Diagnostics Market Drivers
5.3.3 Tuberculosis (TB) Diagnostics Market Challenges
5.3.4 Tuberculosis (TB) Diagnostics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
6.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2019-2024)
6.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2019-2024)
6.2 Global Tuberculosis (TB) Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served
6.4 Global Tuberculosis (TB) Diagnostics Players, Product Type & Application
6.5 Global Tuberculosis (TB) Diagnostics Players, Date of Enter into This Industry
6.6 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
7.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Tuberculosis (TB) Diagnostics Market Size (2019-2030)
8.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
8.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2019-2030)
9.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
9.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
10.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2019-2030)
11.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
11.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Danaher
12.1.1 Danaher Company Information
12.1.2 Danaher Business Overview
12.1.3 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
12.1.5 Danaher Recent Developments
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Business Overview
12.2.3 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
12.2.5 Roche Recent Developments
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Information
12.3.2 Thermo Fisher Scientific Business Overview
12.3.3 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
12.3.5 Thermo Fisher Scientific Recent Developments
12.4 BD
12.4.1 BD Company Information
12.4.2 BD Business Overview
12.4.3 BD Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
12.4.5 BD Recent Developments
12.5 Abbott
12.5.1 Abbott Company Information
12.5.2 Abbott Business Overview
12.5.3 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
12.5.5 Abbott Recent Developments
12.6 Hologic
12.6.1 Hologic Company Information
12.6.2 Hologic Business Overview
12.6.3 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
12.6.5 Hologic Recent Developments
12.7 Qiagen
12.7.1 Qiagen Company Information
12.7.2 Qiagen Business Overview
12.7.3 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
12.7.5 Qiagen Recent Developments
12.8 BioMerieux
12.8.1 BioMerieux Company Information
12.8.2 BioMerieux Business Overview
12.8.3 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
12.8.5 BioMerieux Recent Developments
12.9 Hain Lifescience
12.9.1 Hain Lifescience Company Information
12.9.2 Hain Lifescience Business Overview
12.9.3 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
12.9.5 Hain Lifescience Recent Developments
12.10 Oxford Immunotec
12.10.1 Oxford Immunotec Company Information
12.10.2 Oxford Immunotec Business Overview
12.10.3 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
12.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
12.10.5 Oxford Immunotec Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
